OPIANT PHARMACEUTICALS, INC. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Jul 31, 2017
Revenues
Royalty revenue
Royalty and licensing revenue
Treatment investment revenue
Grant and contract revenue
Total royalty revenue
Total revenue
Operating expenses
General and administrative
Sales and marketing
Royalty expenses
Selling expenses
License fees
Total operating expenses

Income (loss) from operations
Other income (expense)
Interest income, net
Interest expense
Gain on debt settlement
Loss on foreign exchange
Total other income (expense)
Income (loss) before income taxes
Income tax (expense) benefit
Net income (loss)
Other comprehensive income (loss)
Foreign currency translation adjustments
Total comprehensive income (loss)
Income (loss) per share of common stock:
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted average common stock outstanding
Basic (in shares)
Diluted (in shares)

Comments